U.S. Markets open in 1 hr 13 mins
  • S&P Futures

    4,028.00
    +26.75 (+0.67%)
     
  • Dow Futures

    32,652.00
    +218.00 (+0.67%)
     
  • Nasdaq Futures

    12,939.25
    +49.00 (+0.38%)
     
  • Russell 2000 Futures

    1,769.00
    +21.30 (+1.22%)
     
  • Crude Oil

    70.28
    +1.02 (+1.47%)
     
  • Gold

    1,955.00
    -28.80 (-1.45%)
     
  • Silver

    23.18
    -0.15 (-0.66%)
     
  • EUR/USD

    1.0775
    +0.0010 (+0.0970%)
     
  • 10-Yr Bond

    3.3800
    0.0000 (0.00%)
     
  • Vix

    21.38
    -1.23 (-5.44%)
     
  • GBP/USD

    1.2268
    +0.0037 (+0.3042%)
     
  • USD/JPY

    131.5260
    +0.8250 (+0.6312%)
     
  • BTC-USD

    27,911.64
    +13.01 (+0.05%)
     
  • CMC Crypto 200

    607.66
    -10.73 (-1.74%)
     
  • FTSE 100

    7,472.03
    +66.58 (+0.90%)
     
  • Nikkei 225

    27,476.87
    +91.62 (+0.33%)
     

Why These Two Biotech Stocks Blasted Higher This Week

Why These Two Biotech Stocks Blasted Higher This Week

Two somewhat under-the-radar biotech companies saw their share prices soar this week after agreeing to be acquired. CinCor Pharma (NASDAQ: CINC) is being bought out by deep-pocketed pharmaceutical company AstraZeneca, while Albireo Pharma (NASDAQ: ALBO) is set to be owned by France-based peer Ipsen. Both of these deals are very lucrative, to the point where CinCor's stock rocketed 146% over the course of the week, and Albireo shot 92% skyward, according to data compiled by S&P Global Market Intelligence.